Clinical Trial Update: Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ACTIVE I (Atrial Fibrillation Clopidogrel Trial With Irbesartan) assessing prevention of vascular events; the study is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cardiovascular Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Irbesartan (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Atrial Fibrillation, Cardiovascular Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-10-15